Flow resistance modulated aerosolized active agent delivery
US8408200B2 · kind B2 · utility
66Cited by
136References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 1999 |
| Grant date | Apr 2, 2013 |
| Priority date | — |
| Expiry date | Jan 31, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2202/064
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at a low inspiratory flow rate for an initial period of time to increase bioavailability of the active agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.